Pancreatic Endoplasmic Reticulum Kinase Activation Promotes Medulloblastoma Cell Migration and Invasion through Induction of Vascular Endothelial Growth Factor a e0120252

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jamison, Stephanie ^a,b,c   Lin, Yifeng ^a,b,c,d   Lin, Wensheng ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PANCREATIC ENDOPLASMIC RETICULUM KINASE; PEPTIDES AND PROTEINS; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; 7-METHYL-5-(1-((3-(TRIFLUOROMETHYL)PHENYL)ACETYL)-2,3-DIHYDRO-1H-INDOL-5-YL)-7H-PYRROLO(2,3-D)PYRIMIDIN-4-AMINE; ADENINE; EIF2AK3 PROTEIN, HUMAN; INDOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN KINASE R;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MEDULLOBLASTOMA CELL LINE; METASTASIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL MOTION; CEREBELLUM TUMOR; DRUG EFFECTS; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENINE; CELL LINE, TUMOR; CELL MOVEMENT; CEREBELLAR NEOPLASMS; EIF-2 KINASE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMANS; INDOLES; MEDULLOBLASTOMA; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84929090723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120252     Document Type: Article

References (55)

1. Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006; 86: 1133-1149. PMID: 17015486
2. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011; 334: 1081-1086. doi: 10.1126/science.1209038 PMID: 22116877
3. Pavitt GD, Ron D. New insights into translational regulation in the endoplasmic reticulum unfolded protein response. Cold Spring Harb Perspect Biol. 2012; 4: a012278. doi: 10.1101/cshperspect.a012278 PMID: 22535228
4. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007; 8: 519-529. PMID: 17565364
5. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer. 2004; 4: 966-977. PMID: 15573118
6. Moenner M, Pluquet O, Bouchecareilh M,Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007; 67: 10631-10634. PMID: 18006802
7. Ackerman D, Simon MC. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol. 2014; 24: 472-478. doi: 10.1016/j.tcb.2014.06.001 PMID: 24985940
8. Ranganathan AC, Ohja S, Kourtidis A, Conklin DS, Aguirre-Ghiso JA. Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival. Cancer Res. 2008; 68: 3260-3268. doi: 10.1158/0008-5472.CAN-07-6215 PMID: 18451152
9. Vandewynckel YP, Laukens D, Geerts A, Bogaerts E, Paridaens A, Verhelst X, et al. The paradox of the unfolded protein response in cancer. Anticancer Res. 2013; 33: 4683-4694. PMID: 24222102
10. Fels DR, Koumenis C. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther. 2006; 5: 723-728. PMID: 16861899
11. Atkins C, Liu Q, Minthorn E, Zhang SY, Figueroa DJ, Moss K, et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2013; 73: 1993-2002. doi: 10. 1158/0008-5472.CAN-12-3109 PMID: 23333938
12. Mujcic H, Nagelkerke A, Rouschop KM, Chung S, Chaudary N, Span PN, et al. Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3. Clin Cancer Res. 2013; 19: 6126-6137. doi: 10.1158/1078-0432.CCR-13-0526 PMID: 24045183
13. Lin JH, Li H, Zhang Y, Ron D, Walter P. Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One. 2009; 4: e4170. doi: 10.1371/journal.pone.0004170 PMID: 19137072
14. Huber AL, Lebeau J, Guillaumot P, Pétrilli V, Malek M, Chilloux J, et al. p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose. Mol Cell. 2013; 28: 1049-1059.
15. Martín-Pérez R, Palacios C, Yerbes R, Cano-González A, Iglesias-Serret D, Gil J, et al. Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERKdependent pathway. Cancer Res. 2014; 74: 1766-1777. doi: 10.1158/0008-5472.CAN-13-1747 PMID: 24453000
16. Crawford JR, MacDonald TJ, Packer RJ. Medulloblastoma in childhood: new biological advances. Lancet Neurol. 2007; 6: 1073-1085. PMID: 18031705
17. Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, et al. Medulloblastomics: the end of the beginning. Nat Rev Cancer. 2012; 12: 818-834. doi: 10.1038/nrc3410 PMID: 23175120
18. Lin W, Lin Y, Li J, Harding HP, Ron D, Jamison S. A deregulated integrated stress response promotes interferon-γ-induced medulloblastoma. J Neurosci Res. 2011; 89: 1586-1595. doi: 10.1002/jnr.22693 PMID: 21688289
19. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23: 1011-1027. PMID: 15585754
20. Mercurio AM, Bachelder RE, Bates RC, Chung J. Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. Semin Cancer Biol. 2004; 14: 115-122. PMID: 15018895
21. Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell. 2010; 140: 268-279. doi: 10.1016/j.cell.2009.12.046 PMID: 20141840
22. Slongo ML, Molena B, Brunati AM, Frasson M, Gardiman M, Carli M, et al. Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro Oncol. 2007; 9: 384-392. PMID: 17704359
23. Pereira ER, Liao N, Neale GA, Hendershot LM. Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS One. 2010; 5: e12521. doi: 10.1371/ journal.pone.0012521 PMID: 20824063
24. Pereira ER, Frudd K, Awad W, Hendershot LM. Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF). J Biol Chem. 2014; 289: 3352-3364. doi: 10.1074/ jbc.M113.507194 PMID: 24347168
25. Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, Silber JR. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res. 1995; 7: 493-503. PMID: 8866661
26. Lu PD, Jousse C,Marciniak SJ, Zhang Y, Novoa I, Scheuner D, et al. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J. 2004; 23: 169-179. PMID: 14713949
27. Lin W, Harding HP, Ron D, Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol. 2005; 169: 603-612. PMID: 15911877
28. Lin Y, Jamison S, Lin W. Interferon-γ activates nuclear factor-κ B in oligodendrocytes through a process mediated by the unfolded protein response. PLoS One. 2012; 7: e36408. doi: 10.1371/journal.pone. 0036408 PMID: 22574154
29. Lin W, Lin Y, Li J, Fenstermaker AG, Way SW, Clayton B, et al. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci. 2013; 33: 5980-5991. doi: 10.1523/JNEUROSCI.1636-12.2013 PMID: 23554479
30. Lin Y, Huang G, Jamison S, Li J, Harding HP, Ron D, et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. Am J Pathol. 2014; 184: 507-519. doi: 10.1016/j.ajpath.2013.10.009 PMID: 24269558
31. Lin Y, Pang X, Huang G, Jamison S, Fang J, Harding HP, et al. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of Vanishing White Matter Disease in mice. J Neurosci. 2014; 34: 12182-12191. doi: 10.1523/JNEUROSCI.1373-14.2014 PMID: 25186761
32. Lin W, Lin Y. Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways. J Neurosci Res. 2010; 88:2569-2577. doi: 10.1002/jnr.22425 PMID: 20648647
33. Schmidt EK, Clavarino G, Ceppi M, Pierre P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods. 2009; 6: 275-277. doi: 10.1038/nmeth.1314 PMID: 19305406
34. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulumresident kinase. Nature. 1999; 397: 271-274. PMID: 9930704
35. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell. 2000; 6:1099-1108. PMID: 11106749
36. Qi L, Yang L, Chen H. Detecting and quantitating physiological endoplasmic reticulum stress. Methods Enzymol. 2011; 490: 137-146. doi: 10.1016/B978-0-12-385114-7.00008-8 PMID: 21266248
37. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science. 2005; 307: 935-939. PMID: 15705855
38. Lin W, Kunkler PE, Harding HP, Ron D, Kraig RP, Popko B. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol., 2008; 173: 1508-1517. doi: 10.2353/ajpath.2008.080449 PMID: 18818381
39. Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 2012; 55: 7193-7207. doi: 10.1021/jm300713s PMID: 22827572
40. Harding HP, Zyryanova AF, Ron D. Uncoupling proteostasis and development in vitro with a small molecule inhibitor of the pancreatic endoplasmic reticulum kinase, PERK. J Biol Chem. 2012; 287: 44338-44344. doi: 10.1074/jbc.M112.428987 PMID: 23148209
41. Carmeliet P, Ruiz de Almodovar C. VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci. 2013; 70: 1763-1778. doi: 10.1007/s00018-013-1283-7 PMID: 23475071
42. Nagelkerke A, Bussink J, Mujcic H, Wouters BG, Lehmann S, Sweep FC, et al. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res. 2013; 15: R2. doi: 10.1186/bcr3373 PMID: 23294542
43. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011; 13: 184-190. doi: 10.1038/ncb0311-184 PMID: 21364565
44. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012; 13: 89-102. doi: 10.1038/nrm3270 PMID: 22251901
45. Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008; 14: 2378-2386. doi: 10.1158/1078-0432.CCR-07-1253 PMID: 18413828
46. Hervey-Jumper SL, Garton HJ, Lau D, Altshuler D, Quint DJ, Robertson PL, et al. Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma. J Neurosurg Pediatr. 2014; 14: 121-128. doi: 10.3171/2014.4.PEDS13244 PMID: 24905841
47. Davare MA, Lal S, Peckham JL, Prajapati SI, Gultekin SH, Rubin BP, et al. Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells. Biochem Biophys Res Commun. 2014; 450: 555-560. doi: 10.1016/j.bbrc.2014.06.018 PMID: 24928387
48. Akino T, Han X, Nakayama H, McNeish B, Zurakowski D, Mammoto A, et al. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res. 2014; 74: 3716-3726. doi: 10.1158/ 0008-5472.CAN-13-3116 PMID: 24812271
49. Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL, et al. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des. 2000; 15:29-41. PMID: 10888034
50. Hashizume H, Falcón BL, Kuroda T, Baluk P, Coxon A, Yu D, et al. Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res. 2010; 70:2213-2223. doi: 10.1158/0008-5472.CAN-09-1977 PMID: 20197469
51. Moreira IS, Fernandes PA, Ramos MJ. Vascular endothelial growth factor (VEGF) inhibition-a critical review. Anticancer Agents Med Chem. 2007; 7:223-245. PMID: 17348829
52. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70. PMID: 10647931
53. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
54. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 2005; 24: 3470-3481. PMID: 16148948
55. Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest. 2010; 120: 127-141. doi: 10.1172/JCI40027 PMID: 20038797